UBS Group’s THERATECHNOLOGIES INC COM THER Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-63,651
Closed -$53.5K 10416
2023
Q2
$53.5K Sell
63,651
-4,968
-7% -$4.18K ﹤0.01% 6436
2023
Q1
$55.6K Buy
68,619
+3,493
+5% +$2.83K ﹤0.01% 6376
2022
Q4
$57.3K Sell
65,126
-1,433
-2% -$1.26K ﹤0.01% 6640
2022
Q3
$158K Buy
66,559
+5,299
+9% +$12.6K ﹤0.01% 5307
2022
Q2
$139K Sell
61,260
-7,200
-11% -$16.3K ﹤0.01% 5184
2022
Q1
$168K Sell
68,460
-13,004
-16% -$31.9K ﹤0.01% 5498
2021
Q4
$247K Sell
81,464
-3,637
-4% -$11K ﹤0.01% 5508
2021
Q3
$320K Sell
85,101
-2,043
-2% -$7.68K ﹤0.01% 4999
2021
Q2
$338K Buy
87,144
+12,043
+16% +$46.7K ﹤0.01% 5004
2021
Q1
$290K Sell
75,101
-58,862
-44% -$227K ﹤0.01% 5228
2020
Q4
$335K Buy
133,963
+81,048
+153% +$203K ﹤0.01% 4895
2020
Q3
$117K Sell
52,915
-674
-1% -$1.49K ﹤0.01% 5095
2020
Q2
$107K Sell
53,589
-10,962
-17% -$21.9K ﹤0.01% 5251
2020
Q1
$103K Buy
64,551
+24,700
+62% +$39.4K ﹤0.01% 5272
2019
Q4
$131K Buy
+39,851
New +$131K ﹤0.01% 5865

Other funds holding THER

UBS Group's THER Position: Q3 2023 in Review

UBS Group sold out of THERATECHNOLOGIES INC COM (THER) in Q3 2023, closing a stake of 63,651 shares — an estimated $53.5K sold.

UBS Group first reported a position in THER in Q4 2019 and held it in 15 quarters. The position peaked at $338K in Q2 2021. 2 funds tracked by Wall St. Rank hold THER as of Q3 2023.

  • UBS Group reported no remaining THERATECHNOLOGIES INC COM position as of Q3 2023 after selling out during the quarter.
  • UBS Group sold 63,651 THERATECHNOLOGIES INC COM shares in Q3 2023, an estimated $53.5K.
  • UBS Group first reported a position in THERATECHNOLOGIES INC COM in Q4 2019 and held it in 15 quarters.
  • UBS Group's THERATECHNOLOGIES INC COM position peaked at $338K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held THERATECHNOLOGIES INC COM as of Q3 2023.

Based on UBS Group's 13F filing for Q3 2023, filed 9 Nov 2023.